Stephen D Persell1,2, David T Liss1,2, Theresa L Walunas1,3, Jody D Ciolino4, Faraz S Ahmad3,5,6, Tiffany Brown1, Dustin D French7,8,9, Randy Hountz10, Karen Iversen11, Stacy T Lindau12,13, Dawid Lipiszko1, Jennifer A Makelarski13, Kathryn Mazurek14, Linda Murakami15, Yaw Peprah1, Jennifer Potempa16, Luke V Rasmussen6, Andrew Wang8, Jesi Wang17, Chen Yeh4, Abel N Kho1,3. 1. Department of Medicine, Division of General Internal Medicine and Geriatrics. 2. Center for Primary Care Innovation. 3. Center for Health Information Partnerships, Institute for Public Health and Medicine. 4. Department of Preventive Medicine, Division of Biostatistics. 5. Department of Medicine, Division of Cardiology. 6. Department of Preventive Medicine, Division of Health and Biomedical Informatics. 7. Department of Ophthalmology. 8. Center for Healthcare Studies, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine. 9. Veterans Affairs Health Services Research and Development Service, Chicago, IL. 10. Purdue Healthcare Advisors, West Lafayette, IN. 11. AllianceChicago. 12. Departments of Geriatrics and Palliative Medicine. 13. Obstetrics and Gynecology, University of Chicago, Chicago. 14. School of Health Studies, Northern Illinois University, DeKalb. 15. American Medical Association, Chicago. 16. Telligen, Oak Brook, IL. 17. MetaStar; Madison, WI.
Abstract
BACKGROUND:Effective quality improvement (QI) strategies are needed for small practices. OBJECTIVE: The objective of this study was to compare practice facilitation implementing point-of-care (POC) QI strategies alone versus facilitation implementing point-of-care plus population management (POC+PM) strategies on preventive cardiovascular care. DESIGN: Two arm, practice-randomized, comparative effectiveness study. PARTICIPANTS: Small and mid-sized primary care practices. INTERVENTIONS: Practices worked with facilitators on QI for 12 months to implement POC or POC+PM strategies. MEASURES: Proportion of eligible patients in a practice meeting "ABCS" measures: (Aspirin) Aspirin/antiplatelet therapy for ischemic vascular disease, (Blood pressure) Controlling High Blood Pressure, (Cholesterol) Statin Therapy for the Prevention and Treatment of Cardiovascular Disease, and (Smoking) Tobacco Use: Screening and Cessation Intervention, and the Change Process Capability Questionnaire. Measurements were performed at baseline, 12, and 18 months. RESULTS:A total of 226 practices were randomized, 179 contributed follow-up data. The mean proportion of patients meeting each performance measure was greater at 12 months compared with baseline: Aspirin 0.04 (95% confidence interval: 0.02-0.06), Blood pressure 0.04 (0.02-0.06), Cholesterol 0.05 (0.03-0.07), Smoking 0.05 (0.02-0.07); P<0.001 for each. Improvements were sustained at 18 months. At 12 months, baseline-adjusted difference-in-differences in proportions for the POC+PM arm versus POC was: Aspirin 0.02 (-0.02 to 0.05), Blood pressure -0.01 (-0.04 to 0.03), Cholesterol 0.03 (0.00-0.07), and Smoking 0.02 (-0.02 to 0.06); P>0.05 for all. Change Process Capability Questionnaire improved slightly, mean change 0.30 (0.09-0.51) but did not significantly differ across arms. CONCLUSION: Facilitator-led QI promoting population management approaches plus POC improvement strategies was not clearly superior to POC strategies alone.
RCT Entities:
BACKGROUND: Effective quality improvement (QI) strategies are needed for small practices. OBJECTIVE: The objective of this study was to compare practice facilitation implementing point-of-care (POC) QI strategies alone versus facilitation implementing point-of-care plus population management (POC+PM) strategies on preventive cardiovascular care. DESIGN: Two arm, practice-randomized, comparative effectiveness study. PARTICIPANTS: Small and mid-sized primary care practices. INTERVENTIONS: Practices worked with facilitators on QI for 12 months to implement POC or POC+PM strategies. MEASURES: Proportion of eligible patients in a practice meeting "ABCS" measures: (Aspirin) Aspirin/antiplatelet therapy for ischemic vascular disease, (Blood pressure) Controlling High Blood Pressure, (Cholesterol) Statin Therapy for the Prevention and Treatment of Cardiovascular Disease, and (Smoking) Tobacco Use: Screening and Cessation Intervention, and the Change Process Capability Questionnaire. Measurements were performed at baseline, 12, and 18 months. RESULTS: A total of 226 practices were randomized, 179 contributed follow-up data. The mean proportion of patients meeting each performance measure was greater at 12 months compared with baseline: Aspirin 0.04 (95% confidence interval: 0.02-0.06), Blood pressure 0.04 (0.02-0.06), Cholesterol 0.05 (0.03-0.07), Smoking 0.05 (0.02-0.07); P<0.001 for each. Improvements were sustained at 18 months. At 12 months, baseline-adjusted difference-in-differences in proportions for the POC+PM arm versus POC was: Aspirin 0.02 (-0.02 to 0.05), Blood pressure -0.01 (-0.04 to 0.03), Cholesterol 0.03 (0.00-0.07), and Smoking 0.02 (-0.02 to 0.06); P>0.05 for all. Change Process Capability Questionnaire improved slightly, mean change 0.30 (0.09-0.51) but did not significantly differ across arms. CONCLUSION: Facilitator-led QI promoting population management approaches plus POC improvement strategies was not clearly superior to POC strategies alone.
Authors: Jingzhi Yu; Ann A Wang; Lindsay P Zimmerman; Yu Deng; Thanh-Huyen T Vu; Yacob G Tedla; Nicholas D Soulakis; Faraz S Ahmad; Abel N Kho Journal: J Gen Intern Med Date: 2022-01-08 Impact factor: 6.473
Authors: Theresa L Walunas; Jiancheng Ye; Jennifer Bannon; Ann Wang; Abel N Kho; Justin D Smith; Nicholas Soulakis Journal: Implement Sci Date: 2021-03-31 Impact factor: 7.327
Authors: Abel Kho; Gail L Daumit; Kimberly P Truesdale; Arleen Brown; Amy M Kilbourne; Joseph Ladapo; Soma Wali; Lisa Cicutto; Alicia K Matthews; Justin D Smith; Paris D Davis; Antoinette Schoenthaler; Gbenga Ogedegbe; Nadia Islam; Katherine T Mills; Jiang He; Karriem S Watson; Robert A Winn; June Stevens; Amy G Huebschmann; Stanley J Szefler Journal: Health Serv Res Date: 2022-06 Impact factor: 3.734